Document:

Exhibit 10.104 - Moreci Consulting Agreement

EXHIBIT 10.104

Attachment A
December , 2011

		
	Re:
	Consulting Agreement between Stephen F. Moreci and 

Boston Scientific Corporation

Dear Steve:

This letter constitutes a Consulting Agreement ("Agreement") between you, Stephen F. Moreci (“Consultant”), and Boston Scientific Corporation and its affiliated and associated companies (collectively “Boston Scientific”).
		
	1.
	Field of Consultation: The Consultant hereby contracts with Boston Scientific as an independent contractor, and not as an employee, to perform consulting services related to the development of a global view on price management; creation of an appropriate platform for global price management; and support for mergers and acquisitions. Such services shall be performed under the general direction of the Contract Liaison (as defined below).  

		
	2.
	Term:  The term of this Agreement shall commence on January 1, 2012, and shall be for a period of one (1) year unless mutually extended by both parties.

		
	3.
	Payment:  Boston Scientific will pay Consultant a lump sum amount of Seventy Two Thousand Dollars ($72,000.00) for an expected thirty (30) days of consulting, such payment to be made in a lump sum no sooner than 180 days after Consultant’s Retirement Date from Boston Scientific, and no later than July 31, 2012 (the “Payment Date”).  Boston Scientific will also reimburse Consultant for any necessary and reasonable expenses, including travel expenses as authorized by the Contract Liaison. Payment for such expenses shall be due and payable within 60 days of Consultant presenting receipts for expenses incurred. In the event that Consultant and Boston Scientific mutually agree to extend this Agreement such that Consultant provides more than thirty (30) days of consulting services, those services shall be reimbursed at $1,200.00 per half day, and $2,400.00 per full day, not to exceed One Hundred Thousand Dollars ($100,000.00) in the calendar year 2012.

		
	4.
	Contract Liaison:  The performance of Consulting Services under the Agreement will be coordinated through Michael Phalen, who has been designated as the Contract Liaison for this Agreement (the “Contract Liaison”).  All reports, documents, and communications relating to Boston Scientific will occur through such Contract Liaison, or persons designated by the Contract Liaison.  Boston Scientific may designate a new Contract Liaison by written notice to Consultant.  

		
	5.
	Confidential Information: 

		
	(a)
	“Boston Scientific Confidential Information” shall mean all information disclosed by Boston Scientific to Consultant, including, without limitation, information relating to the Field of Consultation of this Agreement, and all other information regarding Boston Scientific’s past, present, or future research, technology, know-how, ideas, concepts, designs, products, prototypes, processes, machines, manufacture, compositions of matter, business plans and operations, technical information, drawings, specifications, and the like, and any knowledge or information developed by Consultant as a result of work in connection with this Agreement, except information which:

		
	(i)
	is at the time of disclosure, or thereafter becomes, a part of the public domain through no act or omission by Consultant;

		
	(ii)
	is lawfully in the possession of Consultant prior to disclosure by Boston Scientific, as shown by Consultant’s written records; or 

		
	(iii)
	is lawfully disclosed to Consultant by a third party which did not acquire the same under an obligation of confidentiality from or through Boston Scientific, as shown by Consultant’s written records.

		
	(b)
	Consultant will not, without the prior written consent of Boston Scientific, disclose any Boston Scientific Confidential Information to anyone for any reason at any time or use any Boston Scientific Confidential Information for any purpose, except as requested by Boston Scientific. 

		
	(c)
	Consultant will not disclose to Boston Scientific any confidential or proprietary information belonging to any third party without the written consent of such party, or represent as being unrestricted any designs, plans, models, samples, or other writings or products that Consultant knows are covered by valid patent, copyright, or other forms of intellectual property protection.

		
	6.
	Boston Scientific Property:  To the extent that it is provided, the parties agree that all tangible property provided to Consultant in connection with this Agreement, including without limitation all samples, reports, communications, drawings, notes, analyses and materials received from Boston Scientific or produced in connection with this Agreement (collectively, “Boston Scientific Property”), shall be and remain the exclusive property of Boston Scientific.  Consultant agrees to keep and maintain in Consultant’s custody and control any Boston Scientific Property that Consultant receives or develops during the term of this Agreement, and agrees to return or surrender to Boston Scientific all Boston Scientific Property upon termination of this Agreement or otherwise upon request by Boston Scientific.  

		
	7.
	Development Rights:  Consultant shall, during the term of this Agreement and for a period of one (1) year thereafter, promptly report and disclose to Boston Scientific all improvements to Boston Scientific products tested and evaluated by Consultant and all ideas and concepts heard, developed or conceived, either alone or with others, including any ideas and concepts which result in new products or significant enhancements to existing products, while performing the Consulting Services (“Developments”).  Developments shall be the sole and exclusive property of Boston Scientific and are hereby assigned to Boston Scientific without any additional payments to Consultant by Boston Scientific.  It is understood that Boston Scientific shall have the right but not the obligation to initiate, prosecute, maintain and defend any and all patentable ideas and concepts with respect to Developments. Consultant shall provide reasonable assistance to Boston Scientific with respect to any such patents and patent applications, and shall execute all appropriate documents and assignments with respect to any such patents and patent applications.  Consultant agrees not to assert any rights in law or in equity in the Developments.

		
	8.
	Publishing:  During the term of this Agreement and for a period of one (1) year thereafter, Consultant shall submit to Boston Scientific any paper Consultant intends to publish relating to the Field of Consultation of this Agreement, and shall not submit any such paper to a publisher or other party prior to the expiration of forty-five (45) days from the date an outline of the paper is submitted to Boston Scientific.  If Boston Scientific determines in good faith during such period that publication or presentation of such paper would be detrimental to its intellectual property interests, Consultant shall work in good faith with Boston Scientific to retract or modify the paper to remove all language which is detrimental to Boston Scientific’s intellectual property interests, or, in the alternative and at Boston Scientific’s election, shall refrain from submitting such paper to a publisher or other party for an additional 120 days to permit Boston Scientific to file patent applications or take other steps to protect its intellectual property interests.  During the term of this Agreement and for a period of one (1) year thereafter, Consultant shall also submit to Company for review, on a confidential basis, any patent applications relating to the Field of Consultation naming Consultant as an inventor, either alone or with others, which Consultant or any third party intends to file with any U.S. or international patent offices in advance of the filing of any such application.  Boston Scientific shall have thirty (30) days in which to review such applications.  If Boston Scientific makes a good faith determination, within such period, that the filing of such an application would be contrary to its intellectual property rights set forth herein, Consultant shall amend, or cause to be amended, such proposed patent application to remove any language that is determined by Boston Scientific to be contrary to its intellectual property rights hereunder.

		
	9.
	Consultant’s Warranties:  Consultant represents and warrants:  

		
	(a)
	that Consultant has the unrestricted right to disclose any information it 

submits to Boston Scientific, free of all claims of third parties; 
		
	(b)
	that such disclosures do not breach or conflict with any confidentiality provisions of any agreement to which Consultant is a party; 

		
	(c)
	that the services covered by this Agreement are not in violation of any other agreement with other parties or of any restrictions of any kind; and

		
	(d)
	that as of the date this Agreement is executed, Consultant is not excluded, debarred, suspended, or otherwise ineligible to participate in U.S. government health care programs (e.g., Medicare, Medicaid, CHAMPUS) or U.S. government procurement and non-procurement programs

		
	10.
	Primacy of Agreement.  This Agreement supersedes and cancels any previous agreements and arrangements between Consultant and Boston Scientific with respect to the Consulting Services that are the subject matter hereof.  This Agreement may be changed only by a writing by both parties.

		
	11.
	Miscellaneous.  This Agreement is made pursuant to the laws of the State of Massachusetts and questions as to its validity and effect shall be governed thereby.  Further, the Agreement is not assignable by Consultant, and shall inure to the benefit of Boston Scientific and its successors and assigns.  Consultant is an independent contractor; is responsible for paying all federal, state and local taxes, including but not limited to income, Social Security and unemployment taxes; and has no right to sign the name of or bind Boston Scientific in any manner; and is not entitled to any benefits for which Boston Scientific employees are eligible.  No failure of either party to enforce any right under the Agreement shall be deemed a waiver thereof.

		
	12.
	Notice:  Any notice or communication required or permitted to be given by either party shall be deemed sufficiently given if mailed by registered mail or by a nationally recognized courier who guarantees overnight delivery and addressed as follows:

To Boston Scientific:                To Consultant:
Michael Phalen                Stephen Moreci    
Boston Scientific Corporation            80 Adin Street
One Boston Scientific Place            Hopedale, MA 01747
Natick, MA 01760
If the foregoing accurately represents our agreement, please sign at the appropriate place and return one copy of this Agreement to me.

BOSTON SCIENTIFIC CORPORATION

Name:  ______________________________            Title: 

(Print)            

Name:  ______________________________        Date:                  
(Signature)

AGREED TO, ACCEPTED AND ACKNOWLEDGED:
    
Stephen F. Moreci        
 
Date:                  
(Signature)Exhibit 10.105 - Leno Retirement Agreement

EXHIBIT 10.105

RETIREMENT AGREEMENT

This Retirement Agreement (“Agreement”) is entered into by and between Samuel R. Leno (“You” or “Employee”) and Boston Scientific Corporation (“BSC”).  This Agreement shall not become effective until the Effective Date (as defined in Paragraph 5(d), below).  This Agreement supersedes and cancels any prior employment agreements or arrangements You may have entered into with BSC except for the Agreement Concerning Employment for U.S. Employees (“Employment Agreement”) acknowledged by You on June 8, 2009 and attached hereto as Attachment 1.  Your obligations under the Employment Agreement shall be in addition or complementary to and shall not be superseded by this Agreement.  However, if there is any conflict in terms between this Agreement and the Employment Agreement, the terms of this Agreement prevail.

In consideration of the mutual covenants, agreements, and representations contained herein, the adequacy of which is hereby acknowledged, the parties hereto expressly and intentionally bind themselves as follows:
            
1.    RETIREMENT FROM EMPLOYMENT

           You hereby acknowledge and agree that you are retiring from your position as Executive Vice President, Chief Operations Officer, with BSC effective December 31, 2011, and that your employment with BSC will end as of that same date (“Retirement Date”).  

2.    PAYMENTS BY BSC

           (a)    Pursuant to the terms of your offer letter of April 11, 2007, you are deemed eligible for benefits equivalent to those under the Boston Scientific Corporation Executive Retirement Plan (the “Executive Retirement Plan”). Accordingly, BSC will make to you a lump sum payment of Six Hundred and Twenty-Nine Thousand, One Hundred and Nine Dollars and Seventy Cents ($629,109.70), representing benefits equivalent to those under the Executive Retirement Plan. Such payment shall be made with the first payroll following June 30, 2012, or as soon thereafter as administratively practical (the “Payment Date”). You further acknowledge that because You are deemed eligible for benefits equivalent to those under the Executive Retirement Plan, all of the terms of the Executive Retirement Plan other than restrictions on eligibility, including without limitation the terms of Section 12 (“Restrictive Covenants”), shall apply to You. You 

expressly acknowledge that upon the occurrence of the Retirement Date, You will not be eligible for any payments or benefits other than those described in this Agreement.

(b)    BSC will pay You for all accrued but unused vacation time through the Retirement Date under applicable BSC policy and in accordance with applicable state law.

(c)    Because You will as of your Retirement Date have met the definition of Retirement with respect to Boston Scientific’s 2011 Performance Incentive Plan (the “2011 PIP”), You will remain eligible for an incentive payment under the 2011 PIP, such payment currently expected to be made in March 2012.  You further agree that any such payment shall be calculated using your target incentive percentage of eighty percent (80%) of your annual base salary, subject to 2011 PIP funding to be determined in the ordinary course.  You will not be eligible for consideration for incentive payments under any other or future Performance Incentive Plan, and You hereby waive any right to such consideration or such payments. 
(d)    Because You will as of your Retirement Date have met the definition of Retirement with respect to your stock options or deferred stock units that are currently unvested, with the exception of those granted to You on February 28, 2011, those options or deferred stock units will vest as of your Retirement Date and become exercisable or will be issued, as applicable, in accordance with the terms and conditions in the applicable agreement(s) and plan document(s). With respect to your stock options or deferred stock units that were granted on February 28, 2011, Boston Scientific has agreed to waive the requirement of continuous service for one year through the first anniversary of grant, and therefore those options and deferred stock units will vest as of your Retirement Date and become exercisable, or will be issued, as applicable, in accordance with the terms and conditions in the applicable agreement(s) and plan document(s).  You will have the full term of the exercise period under each option grant to exercise the options awarded under such grant.

(e)    You will be paid under the Boston Scientific Corporation Executive Allowance Plan in the ordinary course in December 2011 (or as soon thereafter as administratively practical and when such payments are made to other participants), less applicable withholdings for payroll and other taxes. You hereby agree and acknowledge that You will not be entitled to any additional or further payments under the Executive Allowance Plan.

(f)    Because You will as of your Retirement Date have met the definition of Retirement with respect to the 2010 and 2011 Boston Scientific Performance Share Programs (the “PSP Programs”) You will be eligible for prorated award(s) pursuant to the terms and conditions of the PSP Programs. Any such award(s) will be calculated pursuant to the PSP Programs in the ordinary course in January 2012, after the 2011 performance cycle, and the number of prorated 

shares to be issued to the participant, less applicable withholdings for payroll and other taxes, will be approved by the Executive Compensation and Human Resources Committee (the “Compensation Committee”) of the Board of Directors at its next regular meeting thereafter. You hereby agree and acknowledge that you will not be entitled to any additional or further payments under the PSP Programs.

(g)    All payments made pursuant to this Agreement shall be subject to the withholding of such amounts as Boston Scientific reasonably may determine that it is required to withhold pursuant to applicable federal or state law or regulation. Without limiting the generality of the foregoing, the payments pursuant to Paragraphs 2(a), 2(b) and 2(c), above, shall be subject to tax-related withholdings.  Nothing in this Agreement shall be construed to require Boston Scientific to make any payments to compensate You for any adverse tax effect associated with any payments or benefits or for any withholding from any payment.
    
3.    TERMINATION OF EMPLOYMENT BENEFITS

(a)    You agree and acknowledge that your participation and eligibility for future participation in BSC’s 401(k) Plan, Stock Plan(s), and Global Employee Stock Ownership Plan, if any, Accidental Death and Dismemberment (AD&D), Business Travel Accident, and Short-Term and Long-Term Disability Plans will terminate as of your Retirement Date, as will your accrual of vacation time.  You further agree and acknowledge that You will participate through the Retirement Date in all other benefits and benefit plans in which You are currently enrolled to the same extent as do active employees and that your participation in and entitlement to any and all other benefits and benefits plans in which You are currently enrolled, but which are not otherwise specifically addressed in this Agreement, terminate on the Retirement Date.

 (b)    Your participation in BSC’s Medical/Dental/Vision Plans (as well as the participation of any of your dependents who were covered by such Plans one month prior to the Retirement Date) shall continue for Six (6) Months following the Retirement Date (the “Six-Month Period”), on the same terms and conditions as such coverage and/or participation is made available from time to time to BSC employees generally (unless you become eligible for and elect other group medical coverage before the expiration of the Six-Month Period). After the expiration of the Six-Month Period, you may continue your participation in BSC’s Medical/Dental/Vision Plans as provided under the Consolidated Omnibus Budget and Reconciliation Act of 1986 (“COBRA”), should You be eligible for and elect it. During the time of such participation, You will be responsible for making timely payments for the full costs thereof, plus the then applicable costs and fees to continue participation in BSC’s Medical/Dental/Vision Plans for any additional period of time as provided under COBRA.    You further agree to inform BSC immediately if before the end of the 

Six-Month Period you become eligible for any other group health coverage, and of the type and amount of such coverage, as well as to promptly respond to any inquiries from BSC regarding other group health coverage.  You also acknowledge that the terms of BSC’s group health plan coverage offered to BSC employees generally may change from time to time, and that your coverage and/or participation and associated contribution costs will be subject to any such change.

4.    EXPENSE REIMBURSEMENT

BSC will reimburse You in accordance with usual BSC policy for all unreimbursed business travel and other out-of-pocket expenses incurred by You through the Retirement Date in the performance of your duties as an employee of BSC.  Such expenses must be submitted no later than January 31, 2012.

5.    RELEASE BY EMPLOYEE

Except for the rights and benefits provided or referenced in this Agreement, Employee hereby releases and forever discharges BSC and its subsidiaries, affiliates, predecessors, successors, and assigns and the Directors, officers, shareholders, insurers, plans, employees, representatives and agents of each of the foregoing (collectively “Releasees”) of and from the following as of the date of the Employee’s execution of this Agreement:

(a)    Any and all claims, demands, and liabilities whatsoever of every name and nature (other than those arising directly out of this Agreement), including (without limitation) any claim in the nature of so-called whistleblower complaints to the extent permitted by applicable law, and any and all claims, demands and liabilities with respect to Employee’s employment or the terms and conditions or notice of termination or termination of his employment, benefits or compensation which Employee has against Releasees, or ever had, including, without limitation, any claims for benefits under the BSC Severance Pay and Layoff Notification Plan;

(b)    As included in the above, without limitation, all claims known or unknown for tortious injury, breach of contract, and wrongful discharge (including without limitation, any claim for constructive discharge), all claims for infliction of emotional distress, all claims for slander, libel, or defamation of character, all claims of retaliation, and all claims for attorneys’ fees, as related to Employee’s employment, or the terms and conditions or termination of his employment, benefits, or compensation; and 

(c)    Employee specifically releases and forever discharges Releasees from any 

and all claims based upon any allegation of employment discrimination, including (without limitation) discrimination on the basis of race, color, sex, sexual orientation, age (including any claim pursuant to the Federal Age Discrimination in Employment Act (“ADEA”)), religion, disability, genetic information, or national origin.

(d)    Employee acknowledges that he has been given the opportunity, if he so desires, to consider this Agreement for twenty-one (21) days before executing it.  In the event that Employee executes the Agreement within less than twenty-one (21) days of the date of its delivery to him, he acknowledges that such decision was entirely voluntary and that he had the opportunity to consider this Agreement for the entire twenty-one (21) day period.  Employee agrees that any modifications, material or otherwise, made to this Agreement do not restart or affect in any manner the original twenty-one (21) day consideration period.  BSC acknowledges that for a period of seven (7) days from the date of the execution of this Agreement, Employee shall retain the right to revoke this Agreement by written notice to BSC, c/o Otha T. Spriggs III, SVP Human Resources, and that this Agreement shall not become effective or enforceable until the date such revocation period expires (the “Effective Date”).  Therefore, no BSC obligations will be met and payment called for by BSC under Paragraph 2, above, shall not be made until the Effective Date.

6.    NO DAMAGES SOUGHT

Employee represents and states that he has not sought and will not seek or accept any damages or individualized relief in connection with any complaints or charges filed against Releasees with any local, state or federal agency or court, and Employee agrees that if any complaint or charge is filed on his behalf, he shall take all reasonable steps necessary to refuse any damages or individualized relief in connection therewith.

7.    INDEMNIFICATION

You shall have all rights to indemnification with respect to legal claims and legal expenses that are available to current and former officers of BSC under the Certificate of Incorporation and Bylaws of BSC and to you under your Directors and Officers Indemnification Agreement, attached hereto as Attachment 2.
8.    NO LIABILITY ADMITTED

Employee acknowledges that neither BSC’s execution of this Agreement nor BSC’s performance of any of its terms shall constitute an admission by BSC of any wrongdoing by any of the Releasees.

9.    NONDISCLOSURE OF CONFIDENTIAL INFORMATION; RETURN OF BSC PROPERTY

(a)    Employee has throughout his employment with BSC (except as specifically authorized by BSC in the course of his employment) kept, and Employee shall upon his retirement from BSC keep entirely secret and confidential, and shall not disclose to any person or entity, or rely upon or make use of, in any fashion or for any purpose whatsoever, at any time, any information that is (i) not available to the general public, and/or (ii) not generally known outside BSC, regarding Releasees, to which he has had access or about which he heard during the course of his employment by BSC, including (without limitation) any information relating to any of the Releasees’ business or operations; their plans, strategies, prospects or objectives; their products, technology, processes or specifications; their research and development operations or plans; their customers and customer lists; their manufacturing, distribution, procurement, sales, service, support and marketing practices and operations; their financial conditions and results of their operations; their operational strengths and weaknesses; their new business development activities, including but not limited to information regarding any businesses evaluated  in connection with new business development activity; and their personnel and compensation policies, procedures and transactions.  

(b)    In the event Employee is required to testify in any legal proceeding, he shall notify BSC at least ten (10) days prior to such testimony, and any testimony given shall not be a breach of this Agreement.

(c)    Employee agrees to return to BSC, on or before the Retirement Date, documents or media of whatever nature, including summaries containing any of the data referred to in the immediately preceding paragraph whatsoever, including all documents, data, material, details and copies thereof in any form.  Employee agrees to return to BSC, on or before the Termination Date, all BSC property, including (without limitation) any automobile leased to him through BSC, all computer equipment, personal digital assistants, wireless devices, property passes, keys, credit cards, business cards, identification badges, and all sample and demonstration products.  BSC agrees that Employee shall retain use of his company issued laptop, iPad and mobile phone as well as access to the company’s email system for a period of 90 days after the Retirement Date, and BSC shall continue to pay the cost of these devices during this period.

10.    NO DETRIMENTAL COMMUNICATIONS

Employee agrees that he will not make or cause to be disclosed any negative, adverse 

or derogatory statements to any media outlet, industry group, financial institution or current or former employee, consultant, client or customer of the Releasees regarding any of the Releasees or about any of the Releasees’ products or services, business affairs, financial condition or prospects for the future.  Furthermore, Employee hereby represents to BSC that he has made no such communication, and Employee acknowledges that BSC relies upon this representation in agreeing to enter into this Agreement.  

11.    FUTURE ASSISTANCE 

Boston Scientific may seek the assistance, cooperation or truthful testimony of Employee in connection with any investigation, litigation, patent application or prosecution, or intellectual property or other proceeding arising out of matters within the knowledge of Employee and/or related to his position as an employee of Boston Scientific, and in any such instance, Employee shall provide such assistance, cooperation or truthful testimony and Boston Scientific shall pay Employee’s reasonable costs in connection therewith.  
        
		
	12.
	POST-EMPLOYMENT RESTRICTIONS ON COMPETITION AND SOLICITATION OF EMPLOYEES

Employee acknowledges that he is subject to post-employment restrictions on competition and solicitation of BSC employees, in accordance with the terms of his Employment Agreement, attached hereto as Attachment 1.   

13.    CONFIDENTIALITY

Employee acknowledges and understands that the terms of this Agreement may be filed in accordance with the rules and regulations of the Securities and Exchange Commission and may therefore become publicly available. 

14.        FAILURE TO MEET OBLIGATIONS
    
In the event of a material breach of Paragraphs 9, 10, or 12, above, Employee shall repay to BSC the entire amount paid under Paragraph 2(a), above, and shall be liable, moreover, for any damages which a court may determine and shall be subject to injunctive relief, damages, and any other relief which a court may award.

15.    RESIGNATIONS

If Employee is an officer, authorized signatory or member of the board of directors of BSC or of any of the Releasees or any of their affiliated companies, Employee hereby agrees to cooperate in the execution of any document reasonably requested to evidence Employee’s resignation from such position(s), such cooperation to occur both before and after the Retirement Date.  

16.    GOVERNING LAW; SEVERABILITY

This Agreement is entered into and shall be construed under the laws of the Commonwealth of Massachusetts, without regard to its conflict of laws rules.  In the event any provision of this Agreement is determined to be illegal or unenforceable by a duly authorized court of competent jurisdiction, then the remainder of this Agreement shall not be affected thereby, it being the intention of the parties that each provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.  Except as provided immediately below, if any portion of the Release language in Paragraph 5, above, were ruled to be unenforceable for any reason, Employee shall return the consideration provided under Paragraph 2(a), above, to BSC upon demand by BSC, which demand shall be made if Employee were to file any claims against any of the Releasees in violation of this Agreement, especially Paragraph 6.  The foregoing sentence shall not apply to Employee’s pursuit of an ADEA charge with the EEOC or lawsuit challenging the waiver of ADEA claims.

17.    WAIVERS; AMENDMENTS

The failure of either party to require the performance of any term or obligation of this Agreement, or the waiver by either party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation and shall not be deemed a waiver of any subsequent breach.  No modification, alteration, or change or waiver of any provision of this Agreement shall be effective unless in writing and signed by both parties wherein specific reference is made to this Agreement.

18.    NO OTHER INDUCEMENTS

This Agreement sets forth the entire understanding of the parties in connection with its subject matter.  Any and all prior negotiations are merged in this Agreement.  Neither of the parties has made any settlement, representation or warranty in connection with the issues addressed in this Agreement (except those expressly set forth in this Agreement) which has been relied upon by the other party, or which acted as an inducement for the other party to enter into this Agreement.

19.    PERSONS BOUND BY THE AGREEMENT

This Agreement shall be binding upon and inure to the benefit of Employee and to the benefit of each of the Releasees and their respective successors and assigns.

20.    ASSIGNMENT OF INTERESTS

Employee warrants that he has not assigned, or transferred or purported to assign or transfer any claim against Releasees.

21.    PREVAILING PARTY ENTITLED TO FEES

In the event that any action or proceeding is initiated to enforce or interpret the provisions of this Agreement, or to recover for a violation of the Agreement, the prevailing party in any such action or proceeding shall be entitled to its costs (including reasonable attorneys’ fees); provided that if the Employee files a lawsuit challenging the waiver of ADEA claims contained herein, the prevailing party will be entitled to its costs, including reasonable attorneys’ fees only to the extent specifically authorized under federal law.

22.    REPRESENTATION

BSC hereby advises Employee to consult an attorney of his choice before executing this Agreement.  Employee represents that, prior to executing this Agreement, he was advised to and had the opportunity to review the provisions of this Agreement with counsel of his choice.

The parties have read the foregoing Agreement and know its contents, and know that its terms are contractual and legally binding.  The parties further agree that they enter this Agreement voluntarily and that they have not been pressured or coerced in any way into signing this Agreement.

IN WITNESS WHEREOF, the parties hereby agree:

By:    ____________________________    __________________________
Samuel R. Leno            Date

BOSTON SCIENTIFIC CORPORATION

By:    ____________________________    ___________________________
Signature            Date

William H. Kucheman
Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]